参考文献
[1]Couto CA, Bittencourt PL, Porta G, et al.Antismooth muscle and antiactin antibody are indirect markers of histological and biochemical activity of autoimmune hepatitis[J].Hepatology, 2014, 59(2): 592—600.
[2]Chretien-Leprince P, Ballot E, Andre C, et al.Diagnostic value of anti-F-actin antibody in a French multicenter study[J].Annals of the New York Academy of Sciences, 2005, 1050(1): 266—273.
[3]Gregorio GV, Portmann B, Reid F, et al.Autoimmune hepatitis in childhood: a 20-year experience[J].Hepatology, 1997, 25(3): 541—547.
[4]Conrad K, Schößler W, Hiepe F, et al.Autoantibodies in organ specif ic autoimmune diseases: a diagnostic reference[M].Lengerich: Pabst Science Publishers, 2017.
[5]Galaski J, Weiler-Normann C, Schakat M, et al.Update of the simplif ied criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing[J].Journal of Hepatology, 2021, 74(2): 312—320.
[6]Von Mühlen CA, Chan EK, Peebles CL, et al.Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virusassociated chronic liver diseases[J].Clinical & Experimental Immunology, 1995, 100(1): 67—74.
[7]Chu CC, Catera R, Hatzi K, et al.Chronic lymphocytic leukemia antibody with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA[J].Blood, The Journal of the American Society of Hematology, 2008, 112(13): 5122—5129.
[8]Chu CC, Catera R, Zhang L, et al.Many chronic lymphocytic leukemia antibody recognize apoptotic cells with exposed nonmuscle myosin heavy chain ⅡA: implications for patient outcome and cell of origin[J].Blood, The Journal of the American Society of Hematology, 2010,115(19): 3907—3915.
[9]Divanyan T, Acosta E, Patel D, et al.Anti-vimentin antibody in transplant and disease[J].Human immunology, 2019, 80(8): 602—607.
[10]Kotaska K, Petrak B, Kukacka J, et al.Anti-vimentin antibody and neuron-specif ic enolase in children with neurof ibromatosis type-1[J].Neuroendocrinology Letters, 2007, 28(6): 761—764.
[11]Kinloch AJ, Cascino MD, Dai J, et al.Anti-vimentin antibody: a unique antibody class associated with therapy-resistant lupus nephritis[J].Lupus, 2020, 29(6): 569—577.
[12]Wang XP, Cheng QY, Gu MM, et al.Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis[J].Clinical rheumatology, 2019, 38(7): 1841—1849.
[13]Zhu T, Feng L.Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibody and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients[J].International journal of rheumatic diseases, 2013, 16(2): 157—161.
[14]Kuo YB, Chang CA, Wu YK, et al.Identif ication and clinical association of anti-cytokeratin 18 autoantibody in COPD[J].Immunology letters,2010, 128(2): 131—136.
[15]Connolly AM, Pestronk A, Trotter JL, et al.High-titer selective serum anti-β-tubulin antibody in chronic inflammatory demyelinating polyneuropathy[J].Neurology, 1993, 43(3 Pt 1): 557—562.
[16]Guilbert B, Dighiero G, Avrameas S.Naturally occurring antibody against nine common antigens in human sera.I.Detection, isolation and characterization[J].The Journal of Immunology, 1982, 128(6): 2779—2787.
[17]Zhao Z, Weinstein E, Tuzova M, et al.Cross-reactivity of human lupus anti-DNA antibody with α-actinin and nephritogenic potential[J].Arthritis & Rheumatism: Oき cial Journal of the American College of Rheumatology, 2005, 52(2): 522—530.
[18]Croquefer S, Renaudineau Y, Jousse S, et al.The anti-alpha-actinin test completes anti-DNA determination in systemic lupus erythematosus[J].Annals of the New York Academy of Sciences, 2005, 1050(1): 170—175.
[19]Paul G, Georgios D, Jean-Baptiste N, et al.Double reactivity against actin and α-actinin def ines a severe form of autoimmune hepatitis type 1[J].Journal of Clinical Immunology, 2006, 26(6): 495—505.
[20]Renaudineau Y, Dalekos GN, Guéguen P, et al.Anti-α-actinin antibody cross-react with anti-ssDNA antibody in active autoimmune hepatitis[J].Clinical Reviews in Allergy & Immunology, 2008, 34(3): 321—325.
[21]Zachou K, Oikonomou K, Renaudineau Y, et al.Anti-α actinin antibody as new predictors of response to treatment in autoimmune hepatitis type 1[J].Alimentary pharmacology & therapeutics, 2012, 35(1): 116—125.
[22]Pimentel M, Morales W, Rezaie A, et al.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects[J].PLoS One, 2015, 10(5): e0126438.